Restrictive lung disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Restrictive lung disease (RLD) is a group of diseases characterized by an inability to attain complete expansion of the lungs. This may result from an abnormality in the parenchyma of the lungs or an abnormality outside the lung parenchyma (such as fluid accumulation or musculoskeletal abnormalities) hindering normal lung expansion and thus ability to ventilate normally. Restrictive lung diseases present with a restrictive pattern that includes a decrease in total lung capacity (TLC), respiratory volume (RV), forced vital capacity (FVC), forced expiatory volume (FEV1), and a normal to increased FEV1/FVC, on pulmonary function tests. Unlike obstructive lung disease, characterized by air trapping within the lungs, restrictive lung diseases result in decreased lung volumes and a lower than normal amount of air within the lungs. RLDs include [[acute respiratory distress syndrome]],
Restrictive lung disease (RLD) is a group of diseases characterized by an inability to attain complete expansion of the lungs. This may result from an abnormality in the parenchyma of the lungs or an abnormality outside the lung parenchyma (such as fluid accumulation or [[musculoskeletal]] abnormalities) hindering normal lung expansion and thus ability to ventilate normally. Restrictive lung diseases presents with a restrictive pattern on [[pulmonary function test]] and includes a decrease in [[total lung capacity]] (TLC), [[residual volume]] (RV), [[forced vital capacity]] (FVC), forced expiatory volume (FEV1), and a normal to increased FEV1/FVC ratio. Unlike obstructive lung disease (characterized by air trapping within the lungs), restrictive lung diseases result in decreased lung volumes and a lower than normal amount of air within the lungs. RLDs include [[acute respiratory distress syndrome]], [[hypersensitivity pneumonitis]], [[occupational lung disease|occupational lung diseases]], [[pleural effusion]], [[interstitial lung disease]], [[sarcoidosis]], and neuromuscular diseases such as [[scoliosis]], [[muscular dystrophy]], [[ALS|amyotropic lateral sclerosis (ALS)]], and [[myasthenia gravis]].
[[hypersensitivity pneumonitis]], [[occupational lung disease|occupational lung diseases]], [[pleural effusion]], [[interstitial lung disease]], [[sarcoidosis]], and neuromuscular diseases such as scoliosis, [[muscular dystrophy]], [[ALS|amyotropic lateral sclerosis (ALS)]], and [[myasthenia gravis]].


==Classification==
==Classification==
Line 17: Line 16:
*[[Sarcoidosis]]  
*[[Sarcoidosis]]  
*Neuromuscular diseases
*Neuromuscular diseases
**Scoliosis
**[[Scoliosis]]
**[[Muscular dystrophy]]
**[[Muscular dystrophy]]
**[[ALS|Amyotropic lateral sclerosis (ALS)]]
**[[ALS|Amyotropic lateral sclerosis (ALS)]]
Line 29: Line 28:
|
|
{| class="wikitable"
{| class="wikitable"
! style="background:#4479BA; color: #FFFFFF;" align="center" |Pulmonary Function Test
! align="center" style="background:#4479BA; color: #FFFFFF;" |Pulmonary Function Test
! style="background:#4479BA; color: #FFFFFF;" align="center" |Obstructive Lung Disease
! align="center" style="background:#4479BA; color: #FFFFFF;" |Obstructive Lung Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Restrictive Lung Disease
! align="center" style="background:#4479BA; color: #FFFFFF;" |Restrictive Lung Disease
! rowspan="7" |[[image:Figure 39 03 05f.jpg|thumb|center|Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])]]
! rowspan="7" |[[image:Figure 39 03 05f.jpg|thumb|center|Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |TLC
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Total lung capacity (TLC)'''
|'''↑'''
|'''↑'''
|↓
|↓
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |RV
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Residual volume (RV)'''
|'''↑'''
|'''↑'''
|↓
|↓
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |FVC
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Forced vital capacity (FVC)'''
|↓
|↓
|↓
|↓
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |FEV1
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Forced expiratory volume'''
'''in 1<sup>st</sup> second'''
 
'''(FEV1)'''
|↓↓
|↓↓
|↓
|↓
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |FEV1/FVC
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''FEV1/FVC ratio'''
|↓
|↓
|N to '''↑'''
|N to '''↑'''
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |MVV
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Maximum voluntary ventilation'''
|↓
|↓
|↓
|↓
Line 81: Line 83:


==Differentiating Restrictive Lung Disease from other Diseases==
==Differentiating Restrictive Lung Disease from other Diseases==
Restrictive lung disease must be differentiated from other diseases that cause [[dyspnea]], [[cough]], [[hemoptysis]], and [[fever]] such as [[Acute respiratory distress syndrome|ARDS]], [[hypersensitivity pneumonitis]], [[pneumoconiosis]], [[sarcoidosis]], [[pleural effusion]], [[Interstitial lung disease|interstitial lung disease (ILD)]], [[lymphocytic interstitial pneumonia]], [[obesity]], [[pulmonary eosinophilia]] and [[Neuromuscular disorder|neuromuscular disorders]].
Restrictive lung disease must be differentiated from other diseases that cause [[dyspnea]], [[cough]], [[hemoptysis]], and [[fever]] such as [[Acute respiratory distress syndrome|ARDS]], [[hypersensitivity pneumonitis]], [[pneumoconiosis]], [[sarcoidosis]], [[pleural effusion]], [[Interstitial lung disease|interstitial lung disease (ILD)]], [[lymphocytic interstitial pneumonia]], [[obesity]], [[pulmonary eosinophilia]], and [[Neuromuscular disorder|neuromuscular disorders]].
<small>
 
 
{|  
{|  
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="2" rowspan="3" |Disease
! rowspan="3" colspan="2" |Disease
| colspan="11" |Clinical manifestations
| colspan="11" |Clinical manifestations
! colspan="5" |Diagnosis
! colspan="5" |Diagnosis
Line 114: Line 117:
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Acute respiratory distress syndrome|Acute Respiratory Distress Syndrome]] ([[Acute respiratory distress syndrome|ARDS]])<ref name="pmid23825769">{{cite journal |vauthors=Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H |title=Acute respiratory distress syndrome: new definition, current and future therapeutic options |journal=J Thorac Dis |volume=5 |issue=3 |pages=326–34 |date=June 2013 |pmid=23825769 |pmc=3698298 |doi=10.3978/j.issn.2072-1439.2013.04.05 |url=}}</ref>
| colspan="2" |[[Acute respiratory distress syndrome|Acute Respiratory Distress Syndrome]] ([[Acute respiratory distress syndrome|ARDS]])<ref name="pmid23825769">{{cite journal |vauthors=Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H |title=Acute respiratory distress syndrome: new definition, current and future therapeutic options |journal=J Thorac Dis |volume=5 |issue=3 |pages=326–34 |date=June 2013 |pmid=23825769 |pmc=3698298 |doi=10.3978/j.issn.2072-1439.2013.04.05 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Trauma]]
* [[Trauma]]
* [[Sepsis]]
* [[Sepsis]]
Line 121: Line 124:
* [[Acute pancreatitis]]  
* [[Acute pancreatitis]]  
* [[Aspiration pneumonia]]  
* [[Aspiration pneumonia]]  
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Coarse [[breath sounds]]
* Coarse [[breath sounds]]
* Rhonchi  
* Rhonchi  
* Decreased [[breath sounds]]
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Initially [[respiratory alkalosis]] transforming to respiratory acidosis
* Initially [[respiratory alkalosis]] transforming to respiratory acidosis
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
* [[BNP]] level of less than 100 pg/mL
* [[BNP]] level of less than 100 pg/mL
Line 141: Line 144:
* [[Leukocytosis]]
* [[Leukocytosis]]
* [[Thrombocytopenia]]
* [[Thrombocytopenia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bilateral pulmonary infiltrates
* Bilateral pulmonary infiltrates
** Initially patchy peripheral
** Initially patchy peripheral
Line 148: Line 151:
* Ground glass  
* Ground glass  
* Frank alveolar infiltrate
* Frank alveolar infiltrate
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bronchial dilatation within areas of ground-glass opacification
* Bronchial dilatation within areas of ground-glass opacification
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Hypersensitivity pneumonitis|Hypersensitivity Pneumonitis]]<ref name="pmid26310038">{{cite journal |vauthors=Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, Sverzellati N, Costabel U |title=Hypersensitivity Pneumonitis: A Comprehensive Review |journal=J Investig Allergol Clin Immunol |volume=25 |issue=4 |pages=237–50; quiz follow 250 |date=2015 |pmid=26310038 |doi= |url=}}</ref>
| colspan="2" |[[Hypersensitivity pneumonitis|Hypersensitivity Pneumonitis]]<ref name="pmid26310038">{{cite journal |vauthors=Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, Sverzellati N, Costabel U |title=Hypersensitivity Pneumonitis: A Comprehensive Review |journal=J Investig Allergol Clin Immunol |volume=25 |issue=4 |pages=237–50; quiz follow 250 |date=2015 |pmid=26310038 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* History of [[allergen]] exposure
* History of [[allergen]] exposure
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Diffuse fine bibasilar [[crackles]] 
* Diffuse fine bibasilar [[crackles]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Constitutional symptoms
* Constitutional symptoms
** [[Weight loss]]
** [[Weight loss]]
** Anorexia
** Anorexia
** Muscle weakness
** Muscle weakness
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Neutrophilia
* Neutrophilia
* Elevated [[ESR]]
* Elevated [[ESR]]
Line 177: Line 180:
* Elevated [[immunoglobulin]]
* Elevated [[immunoglobulin]]
* No peripheral blood [[eosinophilia]]<ref name="pmid12484500">{{cite journal |vauthors=Yi ES |title=Hypersensitivity pneumonitis |journal=Crit Rev Clin Lab Sci |volume=39 |issue=6 |pages=581–629 |date=November 2002 |pmid=12484500 |doi=10.1080/10408360290795583 |url=}}</ref>
* No peripheral blood [[eosinophilia]]<ref name="pmid12484500">{{cite journal |vauthors=Yi ES |title=Hypersensitivity pneumonitis |journal=Crit Rev Clin Lab Sci |volume=39 |issue=6 |pages=581–629 |date=November 2002 |pmid=12484500 |doi=10.1080/10408360290795583 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Poorly defined micronodular or diffuse interstitial pattern  
* Poorly defined micronodular or diffuse interstitial pattern  
* In chronic form
* In chronic form
Line 184: Line 187:
** Loss of lung volume
** Loss of lung volume
** Coarse linear opacities  
** Coarse linear opacities  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Ground-glass opacities '''or'''  
* Ground-glass opacities '''or'''  
* Diffusely increased radiodensities
* Diffusely increased radiodensities
Line 192: Line 195:
* Occasionaly thin-walled cysts
* Occasionaly thin-walled cysts
* Mild fibrotic changes 
* Mild fibrotic changes 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical diagnosis
*Clinical diagnosis
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |[[Occupational lung disease|Pneumoconiosis]]<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref>
| rowspan="4" |[[Occupational lung disease|Pneumoconiosis]]<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref>
|[[Occupational lung disease|Silicosis]]<ref name="pmid16545629">{{cite journal |vauthors=du Bois RM |title=Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis |journal=Clin. Chest Med. |volume=27 |issue=1 Suppl 1 |pages=S17–25, v–vi |year=2006 |pmid=16545629 |doi=10.1016/j.ccm.2005.08.001 |url=}}</ref><ref name="pmid21996929">{{cite journal |vauthors=Neghab M, Mohraz MH, Hassanzadeh J |title=Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust |journal=J Occup Health |volume=53 |issue=6 |pages=432–8 |year=2011 |pmid=21996929 |doi= |url=}}</ref>
|[[Occupational lung disease|Silicosis]]<ref name="pmid16545629">{{cite journal |vauthors=du Bois RM |title=Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis |journal=Clin. Chest Med. |volume=27 |issue=1 Suppl 1 |pages=S17–25, v–vi |year=2006 |pmid=16545629 |doi=10.1016/j.ccm.2005.08.001 |url=}}</ref><ref name="pmid21996929">{{cite journal |vauthors=Neghab M, Mohraz MH, Hassanzadeh J |title=Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust |journal=J Occup Health |volume=53 |issue=6 |pages=432–8 |year=2011 |pmid=21996929 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Occupational history
* Occupational history
** Sandblasting
** Sandblasting
Line 205: Line 208:
** Silica flour workers
** Silica flour workers
** Workers in the scouring powder industry
** Workers in the scouring powder industry
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
**Hyperresonant
**Hyperresonant
**Fine [[crackles]]  
**Fine [[crackles]]  
Line 221: Line 224:
**Increased [[tactile fremitus]].
**Increased [[tactile fremitus]].
**Loud P2
**Loud P2
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Increased susceptiblity to [[tuberculosis]].
*Increased susceptiblity to [[tuberculosis]].
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Respiratory acidosis]]
*[[Abnormal sputum]]  
*[[Abnormal sputum]]  
Line 231: Line 234:
*Elevated [[CRP]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
*Elevated [[immunoglobulin]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Small round opacities
* Small round opacities
** Symmetrically distributed
** Symmetrically distributed
** Upper-zone predominance
** Upper-zone predominance
* Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
* Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Nodular changes in lung parenchyma
* Nodular changes in lung parenchyma
* Progressive massive fibrosis
* Progressive massive fibrosis
* Bullae, [[emphysema]]  
* Bullae, [[emphysema]]  
* Pleural, mediastinal, and hilar changes
* Pleural, mediastinal, and hilar changes
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" rowspan="4" |
* [[Lung Biopsy|Lung biopsy]]
* [[Lung Biopsy|Lung biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Asbestosis]]<ref name="pmid10949878">{{cite journal |vauthors=Billings CG, Howard P |title=Asbestos exposure, lung cancer and asbestosis |journal=Monaldi Arch Chest Dis |volume=55 |issue=2 |pages=151–6 |date=April 2000 |pmid=10949878 |doi= |url=}}</ref>
|[[Asbestosis]]<ref name="pmid10949878">{{cite journal |vauthors=Billings CG, Howard P |title=Asbestos exposure, lung cancer and asbestosis |journal=Monaldi Arch Chest Dis |volume=55 |issue=2 |pages=151–6 |date=April 2000 |pmid=10949878 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Shipyard workers
* Shipyard workers
* Pipe fitting
* Pipe fitting
* Insulators
* Insulators
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Hyperresonant
*Fine [[crackles]]  
*Fine [[crackles]]  
Line 266: Line 269:
*Increased [[tactile fremitus]].
*Increased [[tactile fremitus]].
*Loud P2
*Loud P2
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Lung cancer]]
* [[Lung cancer]]
* [[Mesothelioma]]
* [[Mesothelioma]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Respiratory acidosis]]
*[[Abnormal sputum]]  
*[[Abnormal sputum]]  
Line 277: Line 280:
*Elevated [[CRP]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
*Elevated [[immunoglobulin]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Predilection to lower lobes
* Predilection to lower lobes
* Fine and coarse linear, peripheral, reticular opacities
* Fine and coarse linear, peripheral, reticular opacities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Subpleural linear opacities seen parallel to the pleura
* Subpleural linear opacities seen parallel to the pleura
* Basilar lung fibrosis  
* Basilar lung fibrosis  
Line 289: Line 292:
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Berylliosis]]<ref name="pmid19894178">{{cite journal |vauthors=Sood A |title=Current treatment of chronic beryllium disease |journal=J Occup Environ Hyg |volume=6 |issue=12 |pages=762–5 |date=December 2009 |pmid=19894178 |pmc=2774897 |doi=10.1080/15459620903158698 |url=}}</ref> 
|[[Berylliosis]]<ref name="pmid19894178">{{cite journal |vauthors=Sood A |title=Current treatment of chronic beryllium disease |journal=J Occup Environ Hyg |volume=6 |issue=12 |pages=762–5 |date=December 2009 |pmid=19894178 |pmc=2774897 |doi=10.1080/15459620903158698 |url=}}</ref> 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Electronic manufactures
* Electronic manufactures
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Hyperresonant
*Fine [[crackles]]  
*Fine [[crackles]]  
Line 307: Line 310:
*Increased [[tactile fremitus]].
*Increased [[tactile fremitus]].
*Loud P2
*Loud P2
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ----
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | ----
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Respiratory acidosis]]
*[[Abnormal sputum]]  
*[[Abnormal sputum]]  
Line 316: Line 319:
*Elevated [[CRP]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
*Elevated [[immunoglobulin]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Hilar adenopathy  
* Hilar adenopathy  
* Increased interstitial markings.
* Increased interstitial markings.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Ground glass opacification  
* Ground glass opacification  
* Parenchymal nodules
* Parenchymal nodules
Line 326: Line 329:
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Byssinosis]] <ref name="pmid8693449">{{cite journal |vauthors=McL Niven R, Pickering CA |title=Byssinosis: a review |journal=Thorax |volume=51 |issue=6 |pages=632–7 |date=June 1996 |pmid=8693449 |pmc=1090498 |doi= |url=}}</ref>
|[[Byssinosis]] <ref name="pmid8693449">{{cite journal |vauthors=McL Niven R, Pickering CA |title=Byssinosis: a review |journal=Thorax |volume=51 |issue=6 |pages=632–7 |date=June 1996 |pmid=8693449 |pmc=1090498 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Cotton wool workers
* Cotton wool workers
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperresonant
*Hyperresonant
*Fine [[crackles]]  
*Fine [[crackles]]  
Line 344: Line 347:
*Increased [[tactile fremitus]].
*Increased [[tactile fremitus]].
*Loud P2
*Loud P2
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased susceptibility to ''[[Actinomyces]]'' and ''[[Aspergillus]]'' infection.
* Increased susceptibility to ''[[Actinomyces]]'' and ''[[Aspergillus]]'' infection.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Respiratory acidosis]]
*[[Respiratory acidosis]]
*[[Abnormal sputum]]  
*[[Abnormal sputum]]  
Line 354: Line 357:
*Elevated [[CRP]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
*Elevated [[immunoglobulin]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Diffuse air-space consolidation
* Diffuse air-space consolidation
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Pulmonary fibrosis with honeycombing  
* Pulmonary fibrosis with honeycombing  
* Peri bronchovascular distribution of nodules  
* Peri bronchovascular distribution of nodules  
Line 363: Line 366:
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Sarcoidosis]] (stage 2-5)<ref name="pmid27378039">{{cite journal |vauthors=Carmona EM, Kalra S, Ryu JH |title=Pulmonary Sarcoidosis: Diagnosis and Treatment |journal=Mayo Clin. Proc. |volume=91 |issue=7 |pages=946–54 |date=July 2016 |pmid=27378039 |doi=10.1016/j.mayocp.2016.03.004 |url=}}</ref>
| colspan="2" |[[Sarcoidosis]] (stage 2-5)<ref name="pmid27378039">{{cite journal |vauthors=Carmona EM, Kalra S, Ryu JH |title=Pulmonary Sarcoidosis: Diagnosis and Treatment |journal=Mayo Clin. Proc. |volume=91 |issue=7 |pages=946–54 |date=July 2016 |pmid=27378039 |doi=10.1016/j.mayocp.2016.03.004 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* African Americans
* African Americans
* [[Autoimmune]]
* [[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Usually normal
* Usually normal
* Occasional crackles  
* Occasional crackles  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Dermatological lesions|Dermatologic manifestations]]
* [[Dermatological lesions|Dermatologic manifestations]]
* Ocular involvement
* Ocular involvement
Line 384: Line 387:
* Lymphocytic [[meningitis]]
* Lymphocytic [[meningitis]]
* [[Cranial nerve palsies]]  
* [[Cranial nerve palsies]]  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Hypercalcemia]] or [[hypercalciuria]] 
* [[Hypercalcemia]] or [[hypercalciuria]] 
* Elevated [[Vitamin D|1, 25-dihydroxyvitamin D levels]]
* Elevated [[Vitamin D|1, 25-dihydroxyvitamin D levels]]
* Elevated [[angiotensin-converting enzyme]] (ACE)
* Elevated [[angiotensin-converting enzyme]] (ACE)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bilateral hilar [[lymphadenopathy]]
* Bilateral hilar [[lymphadenopathy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* High-resolution CT (HRCT) scanning of the chest may identify  
* High-resolution CT (HRCT) scanning of the chest may identify  
** Active alveolitis  
** Active alveolitis  
** Fibrosis  
** Fibrosis  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Biopsy]]
* [[Biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Pleural effusion|Pleural Effusion]]
| colspan="2" |[[Pleural effusion|Pleural Effusion]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |'''Transudate'''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |'''Transudate'''
* [[Congestive heart failure|CHF]]
* [[Congestive heart failure|CHF]]
* [[Cirrhosis]]  
* [[Cirrhosis]]  
Line 405: Line 408:
* [[Parapneumonic effusion|Parapneumonic causes]] 
* [[Parapneumonic effusion|Parapneumonic causes]] 
* [[Malignancy]]
* [[Malignancy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[tactile fremitus]] 
* Decreased [[tactile fremitus]] 
* Diminished or inaudible [[breath sounds]]
* Diminished or inaudible [[breath sounds]]
* Pleural [[friction rub]]
* Pleural [[friction rub]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Peripheral edema, distended neck veins, and S<sub>3</sub> gallop suggest [[congestive heart failure]].
* Peripheral edema, distended neck veins, and S<sub>3</sub> gallop suggest [[congestive heart failure]].
* Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome.
* Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome.
* Cutaneous changes and ascites suggest liver disease.
* Cutaneous changes and ascites suggest liver disease.
* Lymphadenopathy or a palpable mass suggests malignancy.
* Lymphadenopathy or a palpable mass suggests malignancy.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thoracentesis]] 
* [[Thoracentesis]] 
** [[Exudate]]
** [[Exudate]]
Line 428: Line 431:
** [[LDH]], [[glucose]], [[cytology]]
** [[LDH]], [[glucose]], [[cytology]]
* Other specific labs of underlying etiology
* Other specific labs of underlying etiology
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Supine  
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |Supine  
* Blunting of the costophrenic angle
* Blunting of the costophrenic angle
* Homogenous increase in density spread over the lower lung fields
* Homogenous increase in density spread over the lower lung fields
Lateral decubitus  
Lateral decubitus  
* Free flowing effusion as layers  
* Free flowing effusion as layers  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Thickened pleura
* Thickened pleura
* Mild effusions can aslo be detected
* Mild effusions can aslo be detected
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thoracocentesis]]
* [[Thoracocentesis]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Interstitial lung disease]]<ref name="pmid15316211">{{cite journal |vauthors=Boros PW, Franczuk M, Wesolowski S |title=Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases |journal=Respiration |volume=71 |issue=4 |pages=374–9 |date=2004 |pmid=15316211 |doi=10.1159/000079642 |url=}}</ref>
| colspan="2" |[[Interstitial lung disease]]<ref name="pmid15316211">{{cite journal |vauthors=Boros PW, Franczuk M, Wesolowski S |title=Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases |journal=Respiration |volume=71 |issue=4 |pages=374–9 |date=2004 |pmid=15316211 |doi=10.1159/000079642 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Connective tissue disorder|Connective-tissue disorder]]
* [[Connective tissue disorder|Connective-tissue disorder]]
* [[Pneumoconiosis]]
* [[Pneumoconiosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ++
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | ++
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* End-inspiratory fine [[crackles]]
* End-inspiratory fine [[crackles]]


* [[Wheezing]]
* [[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased A-a gradient
* Increased A-a gradient
* Normal PCO2
* Normal PCO2
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Depending on the underlying cause:
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |Depending on the underlying cause:
* Elevated [[ESR]]
* Elevated [[ESR]]
* Serologic testing for [[ANA]], [[RF]], [[Anti-neutrophil cytoplasmic antibody|ANCA]] & ASCA may be positive
* Serologic testing for [[ANA]], [[RF]], [[Anti-neutrophil cytoplasmic antibody|ANCA]] & ASCA may be positive
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Reticular and/or nodular opacities
* Reticular and/or nodular opacities
* Honeycomb appearance (late finding)
* Honeycomb appearance (late finding)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bilateral reticular and nodular interstitial infiltrates
* Bilateral reticular and nodular interstitial infiltrates
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Video-assisted thoracoscopic lung biopsy
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Video-assisted thoracoscopic lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Interstitial Pneumonia|Lymphocytic Interstitial Pneumonia]]<ref name="pmid10397102">{{cite journal |vauthors=Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H |title=Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT |journal=AJR Am J Roentgenol |volume=173 |issue=1 |pages=71–4 |year=1999 |pmid=10397102 |doi=10.2214/ajr.173.1.10397102 |url=}}</ref>
| colspan="2" |[[Interstitial Pneumonia|Lymphocytic Interstitial Pneumonia]]<ref name="pmid10397102">{{cite journal |vauthors=Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H |title=Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT |journal=AJR Am J Roentgenol |volume=173 |issue=1 |pages=71–4 |year=1999 |pmid=10397102 |doi=10.2214/ajr.173.1.10397102 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Autoimmune]]
* [[Autoimmune]]
* [[Lymphoproliferative disorders]]
* [[Lymphoproliferative disorders]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Wheezing]]
* [[Wheezing]]
* [[Rales]]
* [[Rales]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased A-a gradient
* Increased A-a gradient
* Normal PCO2
* Normal PCO2
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Polyclonal hypergammaglobulinemia
* Polyclonal hypergammaglobulinemia
* Increased [[LDH]]
* Increased [[LDH]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Bibasilar interstitial or micronodular infiltrates
* Bibasilar interstitial or micronodular infiltrates
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Determines the degree of fibrosis
* Determines the degree of fibrosis
* Cysts (characterstic)
* Cysts (characterstic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Open lung biopsy
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Open lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Obesity]]<ref name="pmid21116339">{{cite journal |vauthors=Zammit C, Liddicoat H, Moonsie I, Makker H |title=Obesity and respiratory diseases |journal=Int J Gen Med |volume=3 |issue= |pages=335–43 |year=2010 |pmid=21116339 |pmc=2990395 |doi=10.2147/IJGM.S11926 |url=}}</ref><ref name="O’Neill2015">{{cite journal|last1=O’Neill|first1=Donal|title=Measuring obesity in the absence of a gold standard|journal=Economics & Human Biology|volume=17|year=2015|pages=116–128|issn=1570677X|doi=10.1016/j.ehb.2015.02.002}}</ref>
| colspan="2" |[[Obesity]]<ref name="pmid21116339">{{cite journal |vauthors=Zammit C, Liddicoat H, Moonsie I, Makker H |title=Obesity and respiratory diseases |journal=Int J Gen Med |volume=3 |issue= |pages=335–43 |year=2010 |pmid=21116339 |pmc=2990395 |doi=10.2147/IJGM.S11926 |url=}}</ref><ref name="O’Neill2015">{{cite journal|last1=O’Neill|first1=Donal|title=Measuring obesity in the absence of a gold standard|journal=Economics & Human Biology|volume=17|year=2015|pages=116–128|issn=1570677X|doi=10.1016/j.ehb.2015.02.002}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Overweight
* Overweight
* [[Diabetes mellitus]]
* [[Diabetes mellitus]]
* [[Asthma]]
* [[Asthma]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Wheezing]]
* [[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Polycythemia|Increased hematocrit]]
* [[Polycythemia|Increased hematocrit]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* X ray findings are often limited due to body habitus
* X ray findings are often limited due to body habitus
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* CT findings are variable and depends upon severity of obesity
* CT findings are variable and depends upon severity of obesity
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Clinical
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Eosinophilia|Pulmonary Eosinophilia]]<ref name="pmid19706907">{{cite journal |vauthors=de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML |title=Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma |journal=Am. J. Trop. Med. Hyg. |volume=81 |issue=3 |pages=424–7 |year=2009 |pmid=19706907 |doi= |url=}}</ref>
| colspan="2" |[[Eosinophilia|Pulmonary Eosinophilia]]<ref name="pmid19706907">{{cite journal |vauthors=de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML |title=Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma |journal=Am. J. Trop. Med. Hyg. |volume=81 |issue=3 |pages=424–7 |year=2009 |pmid=19706907 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Infections
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |Infections
* [[Parasitic]]
* [[Parasitic]]
* [[Fungal]]
* [[Fungal]]
* [[Mycobacterial]]
* [[Mycobacterial]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Wheezing]]
* [[Wheezing]]
* [[Rales]]
* [[Rales]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Increased A-a gradient
* Increased A-a gradient
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Leukocytosis]] with [[eosinophilia]] (> 250/µL)
* [[Leukocytosis]] with [[eosinophilia]] (> 250/µL)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |
* Interstitial or diffuse nodular densities
* Interstitial or diffuse nodular densities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Determines extent and distribution of the disease
* Determines extent and distribution of the disease


* Interstitial infiltrates
* Interstitial infiltrates
* Cysts and nodules
* Cysts and nodules
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Biopsy of lesion (skin or lung)
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Biopsy of lesion (skin or lung)
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |Neuromuscular disease<ref name="pmid9886443">{{cite journal |vauthors=Polkey MI, Lyall RA, Moxham J, Leigh PN |title=Respiratory aspects of neurological disease |journal=J. Neurol. Neurosurg. Psychiatry |volume=66 |issue=1 |pages=5–15 |date=January 1999 |pmid=9886443 |pmc=1736177 |doi= |url=}}</ref>
| rowspan="4" |Neuromuscular disease<ref name="pmid9886443">{{cite journal |vauthors=Polkey MI, Lyall RA, Moxham J, Leigh PN |title=Respiratory aspects of neurological disease |journal=J. Neurol. Neurosurg. Psychiatry |volume=66 |issue=1 |pages=5–15 |date=January 1999 |pmid=9886443 |pmc=1736177 |doi= |url=}}</ref>
|Scoliosis<ref name="pmid18724205">{{cite journal |vauthors=Bowen RE, Scaduto AA, Banuelos S |title=Decreased body mass index and restrictive lung disease in congenital thoracic scoliosis |journal=J Pediatr Orthop |volume=28 |issue=6 |pages=665–8 |date=September 2008 |pmid=18724205 |doi=10.1097/BPO.0b013e3181841ffd |url=}}</ref>
|Scoliosis<ref name="pmid18724205">{{cite journal |vauthors=Bowen RE, Scaduto AA, Banuelos S |title=Decreased body mass index and restrictive lung disease in congenital thoracic scoliosis |journal=J Pediatr Orthop |volume=28 |issue=6 |pages=665–8 |date=September 2008 |pmid=18724205 |doi=10.1097/BPO.0b013e3181841ffd |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Postural abnormality
* Postural abnormality
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
* In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* R/0 genetic conditions
* R/0 genetic conditions
** [[Marfan's syndrome]]
** [[Marfan's syndrome]]
Line 576: Line 579:
* Total [[Lymphocyte|lymphocyte count]] (should be >1500/μL)
* Total [[Lymphocyte|lymphocyte count]] (should be >1500/μL)
* Nutritional status must be assessed  
* Nutritional status must be assessed  
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
* Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* N/A
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Clinical
* Clinical
* Radiographs
* Radiographs
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Muscular dystrophy]]
|[[Muscular dystrophy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Proximal muscle weakness  
* Proximal muscle weakness  
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Rash]]
* [[Rash]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Elevated [[CPK]] and [[aldolase]]
* Elevated [[CPK]] and [[aldolase]]
* [[Antinuclear antibodies|+ANA]]
* [[Antinuclear antibodies|+ANA]]
* +Anti-Jo abs
* +Anti-Jo abs
* Elevated [[ESR]], [[C-reactive protein|CRP]] and [[RF]]
* Elevated [[ESR]], [[C-reactive protein|CRP]] and [[RF]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* N/A
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* N/A
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Muscle biopsy]]
* [[Muscle biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[ALS]]<ref name="pmid9230256">{{cite journal |vauthors=Vitacca M, Clini E, Facchetti D, Pagani M, Poloni M, Porta R, Ambrosino N |title=Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis |journal=Eur. Respir. J. |volume=10 |issue=7 |pages=1614–21 |date=July 1997 |pmid=9230256 |doi= |url=}}</ref>
|[[ALS]]<ref name="pmid9230256">{{cite journal |vauthors=Vitacca M, Clini E, Facchetti D, Pagani M, Poloni M, Porta R, Ambrosino N |title=Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis |journal=Eur. Respir. J. |volume=10 |issue=7 |pages=1614–21 |date=July 1997 |pmid=9230256 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Muscle weakness
* Muscle weakness
* Neurological deficit
* Neurological deficit
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Symptoms begin with limb involvement diue to muscle weakness and atrophy. 
* Symptoms begin with limb involvement diue to muscle weakness and atrophy. 
* Cognitive or behavioral dysfunction
* Cognitive or behavioral dysfunction
* Sensory nerves and the autonomic nervous system are generally unaffected
* Sensory nerves and the autonomic nervous system are generally unaffected
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/A
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Not significant/diagnostic
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Not significant/diagnostic
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Not significant/diagnostic
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Not significant/diagnostic
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Clinical diagnosis
* Clinical diagnosis
* Nerve conduction studies and needle [[electromyography]] (EMG) 
* Nerve conduction studies and needle [[electromyography]] (EMG) 
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Myasthenia gravis]]<ref name="pmid2040830">{{cite journal |vauthors=Roy TM, Walker JF, Farrow JR |title=Respiratory failure associated with myasthenia gravis |journal=J Ky Med Assoc |volume=89 |issue=4 |pages=169–73 |date=April 1991 |pmid=2040830 |doi= |url=}}</ref>
|[[Myasthenia gravis]]<ref name="pmid2040830">{{cite journal |vauthors=Roy TM, Walker JF, Farrow JR |title=Respiratory failure associated with myasthenia gravis |journal=J Ky Med Assoc |volume=89 |issue=4 |pages=169–73 |date=April 1991 |pmid=2040830 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |H/O of difficulty getting up from chair
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |H/O of difficulty getting up from chair
* Combing
* Combing
* [[Dysphagia|Difficulty in swallowing]]
* [[Dysphagia|Difficulty in swallowing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Decreased [[breath sounds]]
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Extraocular, bulbar, or proximal limb muscles.
* Extraocular, bulbar, or proximal limb muscles.
* Breathing as rapid and shallow
* Breathing as rapid and shallow
* Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation.
* Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Anti–acetylcholine receptor (AChR) antibody (Ab) test +
* Anti–acetylcholine receptor (AChR) antibody (Ab) test +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thymoma]] as an anterior mediastinal mass.
* [[Thymoma]] as an anterior mediastinal mass.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Thymoma]] as an anterior mediastinal mass.
* [[Thymoma]] as an anterior mediastinal mass.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* [[Electromyography]]
* [[Electromyography]]
|}
|}
Line 680: Line 683:
{{Medical conditions}}
{{Medical conditions}}
{{Respiratory pathology}}
{{Respiratory pathology}}


[[Category:Disease]]
[[Category:Disease]]

Revision as of 19:00, 20 March 2018

Restrictive Lung Disease Microchapters

Overview

Classification

Acute respiratory distress syndrome
Hypersensitivity pneumonitis
Occupational lung diseases
Pleural Effusion
Interstitial lung disease
Sarcoidosis
Neuromuscular diseases
Scoliosis
Muscular dystrophy
Amyotropic lateral sclerosis (ALS)
Myasthenia gravis

Spirometry Findings in Various Lung Conditions

Approach to Lung Disorders

Differentiating Restrictive Lung Disease from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2], Akshun Kalia M.B.B.S.[3], Usama Talib, BSc, MD [4], Cafer Zorkun, M.D., Ph.D. [5]

Overview

Restrictive lung disease (RLD) is a group of diseases characterized by an inability to attain complete expansion of the lungs. This may result from an abnormality in the parenchyma of the lungs or an abnormality outside the lung parenchyma (such as fluid accumulation or musculoskeletal abnormalities) hindering normal lung expansion and thus ability to ventilate normally. Restrictive lung diseases presents with a restrictive pattern on pulmonary function test and includes a decrease in total lung capacity (TLC), residual volume (RV), forced vital capacity (FVC), forced expiatory volume (FEV1), and a normal to increased FEV1/FVC ratio. Unlike obstructive lung disease (characterized by air trapping within the lungs), restrictive lung diseases result in decreased lung volumes and a lower than normal amount of air within the lungs. RLDs include acute respiratory distress syndrome, hypersensitivity pneumonitis, occupational lung diseases, pleural effusion, interstitial lung disease, sarcoidosis, and neuromuscular diseases such as scoliosis, muscular dystrophy, amyotropic lateral sclerosis (ALS), and myasthenia gravis.

Classification

Various diseases that present with a restrictive pattern on pulmonary function tests include:

Spirometry Findings in Various Lung Conditions

Spirometry can help distinguish restrictive lung disease from obstructive lung diseases. On spirometry the findings include:[1][2]

Pulmonary Function Test Obstructive Lung Disease Restrictive Lung Disease
Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])
Total lung capacity (TLC)
Residual volume (RV)
Forced vital capacity (FVC)
Forced expiratory volume

in 1st second

(FEV1)

↓↓
FEV1/FVC ratio N to
Maximum voluntary ventilation

Approach to Lung Disorders

 
 
 
 
 
 
 
 
 
 
 
 
 
Spirometry
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal to high FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obstructive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
Restrictive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bronchodilator therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased FEV1
 
 
 
 
 
 
 
No change in FEV1
 
 
 
Normal DLCO
 
 
 
 
 
 
 
Decreased DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asthma
 
 
 
 
 
 
 
COPD
 
 
 
Chest wall disorders
 
 
 
 
 
 
 
Interstitial Lung Disease
 
 

Differentiating Restrictive Lung Disease from other Diseases

Restrictive lung disease must be differentiated from other diseases that cause dyspnea, cough, hemoptysis, and fever such as ARDS, hypersensitivity pneumonitis, pneumoconiosis, sarcoidosis, pleural effusion, interstitial lung disease (ILD), lymphocytic interstitial pneumonia, obesity, pulmonary eosinophilia, and neuromuscular disorders.


Disease Clinical manifestations Diagnosis
History Symptoms Physical exam Lab findings Pulmonary tests Imaging Gold standard of diagnosis
History/Exposure Dyspnea Cough Hemoptysis Fever Cyanosis Clubbing JVD Peripheral edema Auscultation Other prominent findings DLCO CXR CT Method
Acute Respiratory Distress Syndrome (ARDS)[3] + +/- - - +/- - +/- -
  • Bilateral pulmonary infiltrates
    • Initially patchy peripheral
    • Later diffuse bilateral
  • Ground glass
  • Frank alveolar infiltrate
  • Bronchial dilatation within areas of ground-glass opacification
  • PaO2 / FiO2 <300
Hypersensitivity Pneumonitis[4] + + - + - + - -
  • Constitutional symptoms
  • Poorly defined micronodular or diffuse interstitial pattern
  • In chronic form
    • Fibrosis
    • Loss of lung volume
    • Coarse linear opacities
  • Ground-glass opacities or
  • Diffusely increased radiodensities
  • Diffuse micronodules
  • Focal air trapping
  • Mosaic perfusion
  • Occasionaly thin-walled cysts
  • Mild fibrotic changes 
  • Clinical diagnosis
Pneumoconiosis[6] Silicosis[7][8]
  • Occupational history
    • Sandblasting
    • Bystanders
    • Quartzite miller
    • Tunnel workers
    • Silica flour workers
    • Workers in the scouring powder industry
+ + +/- - + + + -
  • Small round opacities
    • Symmetrically distributed
    • Upper-zone predominance
  • Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
  • Nodular changes in lung parenchyma
  • Progressive massive fibrosis
  • Bullae, emphysema
  • Pleural, mediastinal, and hilar changes
Asbestosis[9]
  • Shipyard workers
  • Pipe fitting
  • Insulators
+ + +/- - + + + -
  • Predilection to lower lobes
  • Fine and coarse linear, peripheral, reticular opacities
  • Subpleural linear opacities seen parallel to the pleura
  • Basilar lung fibrosis
  • Peribronchiolar, intralobular, and interlobular septal fibrosis;
  • Honeycombing
  • Pleural plaques.
Berylliosis[10] 
  • Electronic manufactures
+ + +/- - + + + - ----
  • Hilar adenopathy
  • Increased interstitial markings.
  • Ground glass opacification
  • Parenchymal nodules
  • Septal lines
Byssinosis [11]
  • Cotton wool workers
+ + +/- - + + + -
  • Diffuse air-space consolidation
  • Pulmonary fibrosis with honeycombing
  • Peri bronchovascular distribution of nodules
  • Ground-glass attenuations
Sarcoidosis (stage 2-5)[12] + + + + - - - -
  • Usually normal
  • Occasional crackles
  • High-resolution CT (HRCT) scanning of the chest may identify
    • Active alveolitis
    • Fibrosis
Pleural Effusion Transudate

Exudate

+ + +/- +/- +/- +/- +/- +/-
  • Peripheral edema, distended neck veins, and S3 gallop suggest congestive heart failure.
  • Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome.
  • Cutaneous changes and ascites suggest liver disease.
  • Lymphadenopathy or a palpable mass suggests malignancy.
N Supine
  • Blunting of the costophrenic angle
  • Homogenous increase in density spread over the lower lung fields

Lateral decubitus

  • Free flowing effusion as layers
  • Thickened pleura
  • Mild effusions can aslo be detected
Interstitial lung disease[14] ++ + + - +/- +/- +/- +/-
  • Increased A-a gradient
  • Normal PCO2
Depending on the underlying cause:
  • Elevated ESR
  • Serologic testing for ANA, RF, ANCA & ASCA may be positive
  •  Reticular and/or nodular opacities
  • Honeycomb appearance (late finding)
  • Bilateral reticular and nodular interstitial infiltrates
Video-assisted thoracoscopic lung biopsy
Lymphocytic Interstitial Pneumonia[15] + + + + - + - -
  • Increased A-a gradient
  • Normal PCO2
  • Polyclonal hypergammaglobulinemia
  • Increased LDH
N
  • Bibasilar interstitial or micronodular infiltrates
  • Determines the degree of fibrosis
  • Cysts (characterstic)
Open lung biopsy
Obesity[16][17] + + - - - - - + - N
  • X ray findings are often limited due to body habitus
  • CT findings are variable and depends upon severity of obesity
Clinical
Pulmonary Eosinophilia[18] Infections + + + + + - + +
  • Increased A-a gradient
  • Interstitial or diffuse nodular densities
  • Determines extent and distribution of the disease
  • Interstitial infiltrates
  • Cysts and nodules
Biopsy of lesion (skin or lung)
Neuromuscular disease[19] Scoliosis[20]
  • Postural abnormality
+ - - - - - - -
  • In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
N
  • Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
  • N/A
  • Clinical
  • Radiographs
Muscular dystrophy
  • Proximal muscle weakness
+ - - - - - - - N
  • N/A
  • N/A
ALS[21]
  • Muscle weakness
  • Neurological deficit
+ - - - - - - -
  • Symptoms begin with limb involvement diue to muscle weakness and atrophy. 
  • Cognitive or behavioral dysfunction
  • Sensory nerves and the autonomic nervous system are generally unaffected
N/A N Not significant/diagnostic Not significant/diagnostic
Myasthenia gravis[22] H/O of difficulty getting up from chair + - - + - - - -
  • Extraocular, bulbar, or proximal limb muscles.
  • Breathing as rapid and shallow
  • Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation.
  • Anti–acetylcholine receptor (AChR) antibody (Ab) test +
N
  • Thymoma as an anterior mediastinal mass.
  • Thymoma as an anterior mediastinal mass.

References

  1. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J (November 2005). "Interpretative strategies for lung function tests". Eur. Respir. J. 26 (5): 948–68. doi:10.1183/09031936.05.00035205. PMID 16264058.
  2. Mehrparvar AH, Sakhvidi MJ, Mostaghaci M, Davari MH, Hashemi SH, Zare Z (2014). "Spirometry values for detecting a restrictive pattern in occupational health settings". Tanaffos. 13 (2): 27–34. PMC 4260070. PMID 25506373.
  3. Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H (June 2013). "Acute respiratory distress syndrome: new definition, current and future therapeutic options". J Thorac Dis. 5 (3): 326–34. doi:10.3978/j.issn.2072-1439.2013.04.05. PMC 3698298. PMID 23825769.
  4. Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, Sverzellati N, Costabel U (2015). "Hypersensitivity Pneumonitis: A Comprehensive Review". J Investig Allergol Clin Immunol. 25 (4): 237–50, quiz follow 250. PMID 26310038.
  5. Yi ES (November 2002). "Hypersensitivity pneumonitis". Crit Rev Clin Lab Sci. 39 (6): 581–629. doi:10.1080/10408360290795583. PMID 12484500.
  6. Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ (1998). "Idiopathic pulmonary fibrosis: predicting response to therapy and survival". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1063–72. doi:10.1164/ajrccm.157.4.9703022. PMID 9563720.
  7. du Bois RM (2006). "Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis". Clin. Chest Med. 27 (1 Suppl 1): S17–25, v–vi. doi:10.1016/j.ccm.2005.08.001. PMID 16545629.
  8. Neghab M, Mohraz MH, Hassanzadeh J (2011). "Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust". J Occup Health. 53 (6): 432–8. PMID 21996929.
  9. Billings CG, Howard P (April 2000). "Asbestos exposure, lung cancer and asbestosis". Monaldi Arch Chest Dis. 55 (2): 151–6. PMID 10949878.
  10. Sood A (December 2009). "Current treatment of chronic beryllium disease". J Occup Environ Hyg. 6 (12): 762–5. doi:10.1080/15459620903158698. PMC 2774897. PMID 19894178.
  11. McL Niven R, Pickering CA (June 1996). "Byssinosis: a review". Thorax. 51 (6): 632–7. PMC 1090498. PMID 8693449.
  12. Carmona EM, Kalra S, Ryu JH (July 2016). "Pulmonary Sarcoidosis: Diagnosis and Treatment". Mayo Clin. Proc. 91 (7): 946–54. doi:10.1016/j.mayocp.2016.03.004. PMID 27378039.
  13. Iannuzzi MC, Rybicki BA, Teirstein AS (November 2007). "Sarcoidosis". N. Engl. J. Med. 357 (21): 2153–65. doi:10.1056/NEJMra071714. PMID 18032765.
  14. Boros PW, Franczuk M, Wesolowski S (2004). "Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases". Respiration. 71 (4): 374–9. doi:10.1159/000079642. PMID 15316211.
  15. Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H (1999). "Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT". AJR Am J Roentgenol. 173 (1): 71–4. doi:10.2214/ajr.173.1.10397102. PMID 10397102.
  16. Zammit C, Liddicoat H, Moonsie I, Makker H (2010). "Obesity and respiratory diseases". Int J Gen Med. 3: 335–43. doi:10.2147/IJGM.S11926. PMC 2990395. PMID 21116339.
  17. O’Neill, Donal (2015). "Measuring obesity in the absence of a gold standard". Economics & Human Biology. 17: 116–128. doi:10.1016/j.ehb.2015.02.002. ISSN 1570-677X.
  18. de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML (2009). "Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma". Am. J. Trop. Med. Hyg. 81 (3): 424–7. PMID 19706907.
  19. Polkey MI, Lyall RA, Moxham J, Leigh PN (January 1999). "Respiratory aspects of neurological disease". J. Neurol. Neurosurg. Psychiatry. 66 (1): 5–15. PMC 1736177. PMID 9886443.
  20. Bowen RE, Scaduto AA, Banuelos S (September 2008). "Decreased body mass index and restrictive lung disease in congenital thoracic scoliosis". J Pediatr Orthop. 28 (6): 665–8. doi:10.1097/BPO.0b013e3181841ffd. PMID 18724205.
  21. Vitacca M, Clini E, Facchetti D, Pagani M, Poloni M, Porta R, Ambrosino N (July 1997). "Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis". Eur. Respir. J. 10 (7): 1614–21. PMID 9230256.
  22. Roy TM, Walker JF, Farrow JR (April 1991). "Respiratory failure associated with myasthenia gravis". J Ky Med Assoc. 89 (4): 169–73. PMID 2040830.

Related Chapters

Template:Medical conditions Template:Respiratory pathology

Template:WH Template:WS